Le Lézard
Classified in: Ebola virus, Health, Science and technology
Subject: SVY

Sudden Drop in Replikin Count of the Ebola Virus From Its Peak in 2013 Signaled Prompt Stop of Clinical Outbreak, for Three Years; Current Ebola Replikin Count Indicates Start of Next Ebola Outbreak


BOSTON, April 25, 2018 /PRNewswire/ -- In a seminar to be held at Boston University School of Medicine Health Care Emergency Program, Replikins Ltd will report on the 41-year course of a new phenomenon observed in virus Replikin evolution, resulting in a pre-outbreak approach to pandemic prevention, abbreviated "Drop and Stop."

EBOLA VIRUS MOLECULAR EVOLUTION 1976 to 3.24.2018

Replikins Surveillance Servicetm  has analyzed recorded Pubmed data over the past 41 years for the Replikin Count history and the up-to-date mutations in the Replikin structures, including over 1 million automated Replikins gene sequence analyses of 1,242 Ebola and related specimen glycoproteins which contained Ebola Replikins. (See Figure).

Pandemic Prevention: In addition to Ebola virus, similar "Drop and Stop" phenomena have been found in:

  1. Spontaneous drops and cessation of outbreaks observed by Replikins Surveillance Servicetm in SARS, H5N1, H3N2 , H7N9 and other lethal viruses, in animals and humans (2), and
  2. Experimentally in poultry, after receiving Replikins Synthetic Blocker-Vaccinestm  (2).

Having observed the Drop and Stop phenomenon, both spontaneously and experimentally, actively instituting Drop and Stop should be effective routinely to prevent pandemics from developing.

Specific up-to-date solid phase synthetic Replikins Blocker-Vaccinestm  are available seven days after order for Ebola and other individual viruses of interest locally and globally.

For further information, contact:

Samuel Bogoch, M.D., Ph.D
[email protected] 
646-320-5910
Replikins.com

References:

  1. Google:" Sudden Drop Replikin Count". "447,000 results (0.51 secs)"
  2. Bogoch,S. and Bogoch,ES. Replikins: the chemistry of rapid replication. Begell Press, New York, 2005. (Volume I)
  3. Bogoch,S. and Bogoch,E.S. Killer Replikins, (Volume II). In preparation, 2018.

SOURCE Replikins Ltd.


These press releases may also interest you

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...

at 17:49
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...

at 17:33
The American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient consumer organization in the United States, announced the overwhelming success of its 2024 "Are You O-K+" campaign, which marked May 1 (5.1) as...



News published on and distributed by: